Recombinant Mouse PCSK9/NARC1 Protein (His Tag)(Active)

Recombinant Mouse PCSK9/NARC1 Protein (His Tag)(Active)

SKU #	PKSM040778
Expression Host	HEK293 Cells

Description

Synonyms	FH3,HCHOLA3,NARC-1,Narc1,Neural Apoptosis-Regulated Convertase 1,PC9,Pcsk9,Proprotein Convertase 9,Proprotein Convertase Subtilisin/Kexin Type 9,Subtilisin/Kexin-Like Protease PC9
Species	Mouse
Expression Host	HEK293 Cells
Sequence	Met 1-Gln 694
Accession	NP_705793.1
Calculated Molecular Weight	72.6 kDa
Observed Molecular Weight	19 & 65 kDa
Tag	C-His
Bio-activity	Immobilized mouse PCSK9 at 10 g/ml (100 l/well) can bind biotinylated recombinant human LDLR. The EC50 of biotinylated human LDLR is 0.12 g/ml.

Properties

Purity	> 95 % as determined by reducing SDS-PAGE.
Endotoxin	< 1.0 EU per g of the protein as determined by the LAL method.
Storage	Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80. Reconstituted protein solution can be stored at 4-8 for 2-7 days. Aliquots of reconstituted samples are stable at < -20 for 3 months.
Shipping	This product is provided as lyophilized powder which is shipped with ice packs.
Formulation	Lyophilized from sterile 15mM Tris, 90mM NaCl, 50% Glycerol, pH 7.5 Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual.
Reconstitution	Please refer to the printed manual for detailed information.

Background

Proprotein convertase subtilisin/kexin type 9 (PCSK9), also known as NARC1 (neural apoptosis regulated convertase), which is a newly identified human secretory subtilase belonging to the proteinase K subfamily of the secretory subtilase family. PCSK9 protein is an enzyme which in humans is encoded by the PCSK9 gene with orthologs found across many species. It is expressed in neuroepithelioma, colon carcinoma, hepatic and pancreatic cell lines, and in Schwann cells. PCSK9 protein is highly expressed in the liver and regulates low density lipoprotein receptor (LDLR) protein levels. Inhibition of PCSK9 protein function is currently being explored as a means of lowering cholesterol levels. Thereby, PCSK9 protein is regarded as a new strategy to treat hypercholesterolemia. PCSK9 protein contributes to cholesterol homeostasis and may have a role in the differentiation of cortical neurons.